Sildenafil affects the human Kir2.1 and Kir2.2 channels at clinically relevant concentrations: Inhibition potentiated by low Ba2

. 2023 ; 14 () : 1136272. [epub] 20230202

Status PubMed-not-MEDLINE Jazyk angličtina Země Švýcarsko Médium electronic-ecollection

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid36817146

Sildenafil (Viagra), the first approved and widely used oral drug for the treatment of erectile dysfunction, was occasionally associated with life-threatening ventricular arrhythmias in patients. Since inward rectifier potassium current (I K1) may considerably contribute to this arrhythmogenesis, we investigated the effect of sildenafil on the human Kir2.1 and Kir2.2, the prevailing subunits forming the ventricular I K1 channels. Experiments were performed by the whole-cell patch clamp technique at 37°C using Chinese hamster ovary cells transiently expressing the human Kir2.1 and Kir2.2 channels. Changes of both the inward and outward current components (at -110 and -50 mV, respectively) were tested to be able to consider the physiological relevance of the sildenafil effect (changes at -110 and -50 mV did not significantly differ, results at -50 mV are listed below). A significant Kir2.1 inhibition was observed at all applied sildenafil concentrations (16.1% ± 3.7%, 20.0% ± 2.6%, and 15.0% ± 3.0% at 0.1, 1, and 10 μM, respectively). The inhibitory effect of 0.1 μM sildenafil was potentiated by the presence of a low concentration of Ba2+ (0.1 μM) which induced only a slight Kir2.1 inhibition by 5.95% ± 0.75% alone (the combined effect was 35.5% ± 3.4%). The subtherapeutic and therapeutic sildenafil concentrations (0.1 and 1 μM) caused a dual effect on Kir2.2 channels whereas a significant Kir2.2 activation was observed at the supratherapeutic sildenafil concentration (10 μM: 34.1% ± 5.6%). All effects were fully reversible. This is the first study demonstrating that sildenafil at clinically relevant concentrations inhibits both the inward and outward current components of the main human ventricular I K1 subunit Kir2.1. This inhibitory effect was significantly potentiated by a low concentration of environmental contaminant Ba2+ in agreement with recently reported data on rat ventricular I K1 which additionally showed a significant repolarization delay. Considering the similar subunit composition of the human and rat ventricular I K1 channels, the observed effects might contribute to sildenafil-associated arrhythmogenesis in clinical practice.

Zobrazit více v PubMed

Alpaslan M., Onrat E., Samli M., Dincel C. (2003). Sildenafil citrate does not affect QT intervals and QT dispersion: An important observation for drug safety. Ann. Noninvasive Electrocardiol. 8 (1), 14–17. 10.1046/j.1542-474x.2003.08103.x PubMed DOI PMC

Azarbal B., Mirocha J., Shah P. K., Cercek B., Kaul S. (2000). Adverse cardiovascular events associated with the use of viagra. J. Am. Coll. Cardiol. 35, 553A. 10.1016/S0735-1097(00)80009-1 DOI

Bosch R. F., Li G. R., Gaspo R., Nattel S. (1999). Electrophysiologic effects of chronic amiodarone therapy and hypothyroidism, alone and in combination, on Guinea pig ventricular myocytes. J. Pharmacol. Exp. Ther. 289 (1), 156–165. PubMed

Chai Y., Zhang D. M., Lin Y. F. (2011). Activation of cGMP-dependent protein kinase stimulates cardiac ATP-sensitive potassium channels via a ROS/calmodulin/CaMKII signaling cascade. PLoS. One. 6 (3), e18191. 10.1371/journal.pone.0018191 PubMed DOI PMC

Cheitlin M. D., Hutter A. M., Jr., Brindis R. G., Ganz P., Kaul S., Russell R. O., Jr., et al. (1999). Use of sildenafil (viagra) in patients with cardiovascular disease. Technology and practice executive committee. Circulation 99 (1), 168–177. 10.1161/01.cir.99.1.168 PubMed DOI

Chiang C. E., Luk H. N., Wang T. M., Ding P. Y. (2002). Effects of sildenafil on cardiac repolarization. Cardiovasc. Res. 55 (2), 290–299. 10.1016/s0008-6363(02)00438-8 PubMed DOI

Cordeiro J. M., Zeina T., Goodrow R., Kaplan A. D., Thomas L. M., Nesterenko V. V., et al. (2015). Regional variation of the inwardly rectifying potassium current in the canine heart and the contributions to differences in action potential repolarization. J. Mol. Cell. Cardiol. 84, 52–60. 10.1016/j.yjmcc.2015.04.010 PubMed DOI PMC

Curtis M. J., Alexander S., Cirino G., Docherty J. R., George C. H., Giembycz M. A., et al. (2018). Experimental design and analysis and their reporting II: Updated and simplified guidance for authors and peer reviewers. Br. J. Pharmacol. 175 (7), 987–993. 10.1111/bph.14153 PubMed DOI PMC

Degerman E., Belfrage P., Manganiello V. C. (1997). Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3). J. Biol. Chem. 272 (11), 6823–6826. 10.1074/jbc.272.11.6823 PubMed DOI

Dhamoon A. S., Jalife J. (2005). The inward rectifier current (Ik1) controls cardiac excitability and is involved in arrhythmogenesis. Heart rhythm. 2 (3), 316–324. 10.1016/j.hrthm.2004.11.012 PubMed DOI

Gaborit N., Le Bouter S., Szuts V., Varro A., Escande D., Nattel S., et al. (2007). Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart. J. Physiol. 582, 675–693. 10.1113/jphysiol.2006.126714 PubMed DOI PMC

Garcia A. M., Nakano S. J., Karimpour-Fard A., Nunley K., Blain-Nelson P., Stafford N. M., et al. (2018). Phosphodiesterase-5 is elevated in failing single ventricle myocardium and affects cardiomyocyte remodeling in vitro . Circ. Heart. Fail. 11 (9), e004571. 10.1161/CIRCHEARTFAILURE.117.004571 PubMed DOI PMC

Geelen P., Drolet B., Rail J., Bérubé J., Daleau P., Rousseau G., et al. (2000). Sildenafil (Viagra) prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current. Circulation 102 (3), 275–277. 10.1161/01.cir.102.3.275 PubMed DOI

Goldstein I., Burnett A. L., Rosen R. C., Park P. W., Stecher V. J. (2019). The serendipitous story of sildenafil: An unexpected oral therapy for erectile dysfunction. Sex. Med. Rev. 7 (1), 115–128. 10.1016/j.sxmr.2018.06.005 PubMed DOI

Irfan M., Hussain N. H. N., Noor N. M., Mohamed M., Sidi H., Ismail S. B. (2020). Epidemiology of male sexual dysfunction in asian and European regions: A systematic review. Am. J. Mens. Health 14 (4), 1557988320937200. 10.1177/1557988320937200 PubMed DOI PMC

Ishikura F., Beppu S., Hamada T., Khandheria B. K., Seward J. B., Nehra A. (2000). Effects of sildenafil citrate (Viagra) combined with nitrate on the heart. Circulation 102 (20), 2516–2521. 10.1161/01.cir.102.20.2516 PubMed DOI

Jalife J. (2009). Inward rectifier potassium channels control rotor frequency in ventricular fibrillation. Heart rhythm. 6, S44–S48. 10.1016/j.hrthm.2009.07.019 PubMed DOI PMC

Kanlop N., Shinlapawittayatorn K., Sungnoon R., Chattipakorn S., Lailerd N., Chattipakorn N. (2008). Sildenafil citrate on the inducibility of ventricular fibrillation and upper limit of vulnerability in swine. Med. Sci. Monit. 14 (10), BR205–BR209. PubMed

Kaya D., Guler C., Esen A. M., Barutcu I., Dincel C. (2004). Sildenafil citrate does not alter ventricular repolarization properties: Novel evidence from dynamic QT analysis. Ann. Noninvasive Electrocardiol. 9 (3), 228–233. 10.1111/j.1542-474X.2004.93554.x PubMed DOI PMC

Kloner R. A. (2000). Cardiovascular risk and sildenafil. Am. J. Cardiol. 86 (2A), 57F–61F. 10.1016/s0002-9149(00)00895-x PubMed DOI

Koumi S., Backer C. L., Arentzen C. E., Sato R. (1995a). Beta-adrenergic modulation of the inwardly rectifying potassium channel in isolated human ventricular myocytes. Alteration in channel response to beta-adrenergic stimulation in failing human hearts. J. Clin. Invest. 96, 2870–2881. 10.1172/JCI118358 PubMed DOI PMC

Koumi S., Wasserstrom J. A., Ten Eick R. E. (1995b). Beta-adrenergic and cholinergic modulation of inward rectifier K+ channel function and phosphorylation in Guinea-pig ventricle. J. Physiol. 486, 661–678. 10.1113/jphysiol.1995.sp020842 PubMed DOI PMC

Kubo M., Nakaya Y., Matsuoka S., Saito K., Kuroda Y. (1994). Atrial natriuretic factor and isosorbide dinitrate modulate the gating of ATP-sensitive K+ channels in cultured vascular smooth muscle cells. Circ. Res. 74 (3), 471–476. 10.1161/01.res.74.3.471 PubMed DOI

Kula R., Bébarová M., Matejovič P., Šimurda J., Pásek M. (2020). Current density as routine parameter for description of ionic membrane current: Is it always the best option? Prog. Biophys. Mol. Biol. 157, 24–32. 10.1016/j.pbiomolbio.2019.11.011 PubMed DOI

Li G. R., Lau C. P., Ducharme A., Tardif J. C., Nattel S. (2002). Transmural action potential and ionic current remodeling in ventricles of failing canine hearts. Am. J. Physiol. Heart Circ. Physiol. 283 (3), H1031–H1041. 10.1152/ajpheart.00105.2002 PubMed DOI

Łukasik-Głębocka M., Sommerfeld K., Hanć A., Grzegorowski A., Barałkiewicz D., Gaca M., et al. (2014). Barium determination in gastric contents, blood and urine by inductively coupled plasma mass spectrometry in the case of oral barium chloride poisoning. J. Anal. Toxicol. 38 (6), 380–382. 10.1093/jat/bku037 PubMed DOI

Macháček M., Švecová O., Bébarová M. (2022). Combination of sildenafil and Ba2+ at a low concentration show a significant synergistic inhibition of inward rectifier potassium current resulting in action potential prolongation. Front. Pharmacol. 13, 829952. 10.3389/fphar.2022.829952 PubMed DOI PMC

Melnyk P., Zhang L., Shrier A., Nattel S. (2002). Differential distribution of Kir2.1 and Kir2.3 subunits in canine atrium and ventricle. Am. J. Physiol. Heart Circ. Physiol. 283 (3), H1123–H1133. 10.1152/ajpheart.00934.2001 PubMed DOI

Nichols D. J., Muirhead G. J., Harness J. A. (2002). Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: Absolute bioavailability, food effects and dose proportionality. Br. J. Clin. Pharmacol. 53, 5S-12S. 10.1046/j.0306-5251.2001.00027.x PubMed DOI PMC

Ogura T., Shuba L. M., McDonald T. F. (1995). Action potentials, ionic currents and cell water in Guinea pig ventricular preparations exposed to dimethyl sulfoxide. J. Pharmacol. Exp. Ther. 273 (3), 1273–1286. PubMed

Packer M., Carver J. R., Rodeheffer R. J., Ivanhoe R. J., DiBianco R., Zeldis S. M., et al. (1991). Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N. Engl. J. Med. 325 (21), 1468–1475. 10.1056/NEJM199111213252103 PubMed DOI

Panama B. K., McLerie M., Lopatin A. N. (2010). Functional consequences of Kir2.1/Kir2.2 subunit heteromerization. Pflugers Arch. 460, 839–849. 10.1007/s00424-010-0864-7 PubMed DOI PMC

Panama B. K., McLerie M., Lopatin A. N. (2007). Heterogeneity of Ik1 in the mouse heart. Am. J. Physiol. Heart Circ. Physiol. 293 (6), H3558–H3567. 10.1152/ajpheart.00419.2007 PubMed DOI

Phillips B. G., Kato M., Pesek C. A., Winnicki M., Narkiewicz K., Davison D., et al. (2000). Sympathetic activation by sildenafil. Circulation 102 (25), 3068–3073. 10.1161/01.cir.102.25.3068 PubMed DOI

Piao L., Li J., McLerie M., Lopatin A. N. (2007). Transgenic upregulation of Ik1 in the mouse heart is proarrhythmic. Basic Res. Cardiol. 102, 416–428. 10.1007/s00395-007-0659-y PubMed DOI

Rasmussen J. G., Toft E., Frøbert O. (2007). Ventricular tachycardia after administration of sildenafil citrate: A case report. J. Med. Case Rep. 1, 65. 10.1186/1752-1947-1-65 PubMed DOI PMC

Reilly L., Eckhardt L. L. (2021). Cardiac potassium inward rectifier Kir2: Review of structure, regulation, pharmacology, and arrhythmogenesis. Heart rhythm. 18, 1423–1434. 10.1016/j.hrthm.2021.04.008 PubMed DOI PMC

Robertson B. E., Schubert R., Hescheler J., Nelson M. T. (1993). cGMP-dependent protein kinase activates Ca-activated K channels in cerebral artery smooth muscle cells. Am. J. Physiol. 265, C299–C303. 10.1152/ajpcell.1993.265.1.C299 PubMed DOI

Salloum F. N., Takenoshita Y., Ockaili R. A., Daoud V. P., Chou E., Yoshida K., et al. (2007). Sildenafil and vardenafil but not nitroglycerin limit myocardial infarction through opening of mitochondrial K(ATP) channels when administered at reperfusion following ischemia in rabbits. J. Mol. Cell. Cardiol. 42 (2), 453–458. 10.1016/j.yjmcc.2006.10.015 PubMed DOI PMC

Schram G., Pourrier M., Wang Z., White M., Nattel S. (2003). Barium block of Kir2 and human cardiac inward rectifier currents: Evidence for subunit-heteromeric contribution to native currents. Cardiovasc. Res. 59, 328–338. 10.1016/s0008-6363(03)00366-3 PubMed DOI

Sekar R. B., Kizana E., Cho H. C., Molitoris J. M., Hesketh G. G., Eaton B. P., et al. (2009). Ik1 heterogeneity affects Genesis and stability of spiral waves in cardiac myocyte monolayers. Circ. Res. 104, 355–364. 10.1161/CIRCRESAHA.108.178335 PubMed DOI PMC

Shaeer O., Shaeer K., Fode M., Serefoglu E. (2017). The global online sexuality survey (GOSS) 2015: Erectile dysfunction among English-speaking internet users in the United States. Hum. Androl. 7 (4), 111–119. 10.21608/HA.2017.1788.1015 DOI

Shan X., Quaile M. P., Monk J. K., French B., Cappola T. P., Margulies K. B. (2012). Differential expression of PDE5 in failing and nonfailing human myocardium. Circ. Heart Fail. 5 (1), 79–86. 10.1161/CIRCHEARTFAILURE.111.961706 PubMed DOI PMC

Shimoda L. A., Welsh L. E., Pearse D. B. (2002). Inhibition of inwardly rectifying K(+) channels by cGMP in pulmonary vascular endothelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 283 (2), L297–L304. 10.1152/ajplung.00469.2001 PubMed DOI

Shinlapawittayatorn K., Chattipakorn S., Chattipakorn N. (2005). Effect of sildenafil citrate on the cardiovascular system. Braz. J. Med. Biol. Res. 38 (9), 1303–1311. 10.1590/s0100-879x2005000900003 PubMed DOI

Sonkusare S. K., Dalsgaard T., Bonev A. D., Nelson M. T. (2016). Inward rectifier potassium (Kir2.1) channels as end-stage boosters of endothelium-dependent vasodilators. J. Physiol. 594 (12), 3271–3285. 10.1113/JP271652 PubMed DOI PMC

Sugiyama A., Satoh Y., Shiina H., Takahara A., Yoneyama M., Hashimoto K. (2001). Cardiac electrophysiologic and hemodynamic effects of sildenafil, a PDE5 inhibitor, in anesthetized dogs. J. Cardiovasc. Pharmacol. 38 (6), 940–946. 10.1097/00005344-200112000-00016 PubMed DOI

Turko I. V., Ballard S. A., Francis S. H., Corbin J. D. (1999). Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (Type 5) by sildenafil and related compounds. Mol. Pharmacol. 56 (1), 124–130. 10.1124/mol.56.1.124 PubMed DOI

Wang Z., Yue L., White M., Pelletier G., Nattel S. (1998). Differential distribution of inward rectifier potassium channel transcripts in human atrium versus ventricle. Circulation 98 (22), 2422–2428. 10.1161/01.cir.98.22.2422 PubMed DOI

Xiao L., Zhang L., Han W., Wang Z., Nattel S. (2006). Sex-based transmural differences in cardiac repolarization and ionic-current properties in canine left ventricles. Am. J. Physiol. Heart Circ. Physiol. 291 (2), H570–H580. 10.1152/ajpheart.01288.2005 PubMed DOI

Zusman R. M., Morales A., Glasser D. B., Osterloh I. H. (1999). Overall cardiovascular profile of sildenafil citrate. Am. J. Cardiol. 83 (5A), 35C–44C. 10.1016/s0002-9149(99)00046-6 PubMed DOI

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...